Digital Health, Technology & InnovationeXoZymes Launches BioClick with $300K NIH GrantGlobeNewswireApril 12, 2025April 14, 2025 by GlobeNewswireApril 12, 2025April 14, 2025021 Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals –...